| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/17/1998 | WO1998040481A1 Novel proline-rich acidic protein |
| 09/17/1998 | WO1998040480A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses |
| 09/17/1998 | WO1998040479A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | WO1998040478A2 Antisense inhibition of human stat-6 |
| 09/17/1998 | WO1998040476A1 PROCESS FOR PRODUCING L-METHIONINE η-LYASE CRYSTALS |
| 09/17/1998 | WO1998040470A2 Cytochrome p450 monooxygenases |
| 09/17/1998 | WO1998040468A1 Methods of constructing a gene mutation library and compounds and compositions thereof |
| 09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | WO1998040407A1 Synaptic activation protein compositions and method |
| 09/17/1998 | WO1998040405A1 Antithrombin protein and dna sequences |
| 09/17/1998 | WO1998040404A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040403A1 Psca: prostate stem cell antigen |
| 09/17/1998 | WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | WO1998040396A1 Multiflavor streptavidin |
| 09/17/1998 | WO1998040394A1 Vector constructs for the selection and identification of open reading frames |
| 09/17/1998 | WO1998040105A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 09/17/1998 | WO1998040099A1 Leptospira pathogens |
| 09/17/1998 | WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998035053A3 Electrochemical analyte sensors using thermostable soybean peroxidase |
| 09/17/1998 | WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells |
| 09/17/1998 | WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/17/1998 | WO1998029138A3 Compositions and methods for tumour therapy |
| 09/17/1998 | WO1998026046A3 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998023777A3 Assay for detecting apoptotic cells |
| 09/17/1998 | WO1998021972A3 Compounds with improved inductive effect on cartilage and bones |
| 09/17/1998 | WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 09/17/1998 | DE19716732A1 Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung Specific magnetosomes, processes for their preparation and their use |
| 09/17/1998 | DE19711266A1 Neue humane Leber-Zellinie New human liver cell line |
| 09/17/1998 | DE19709775A1 Nucleinsäuremoleküle codierend Stärkephosphorylase aus Mais Nucleic acid molecules encoding starch phosphorylase from maize |
| 09/17/1998 | DE19709186A1 Filtrationsverfahren zur Trennung von Viren Filtration methods for separating viruses |
| 09/17/1998 | DE19708774A1 Nucleinsäuremoleküle codierend Enzyme die Fructosylpolymeraseaktivität besitzen Nucleic acid molecules encoding enzymes have the Fructosylpolymeraseaktivität |
| 09/17/1998 | DE19708758A1 Verfahren zum Nachweis von mutierten Allelen A method of detecting mutated alleles |
| 09/17/1998 | CA2287591A1 Synaptic activation protein compositions and method |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284084A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283716A1 Multiflavor streptavidin |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283632A1 Nucleic acid molecules encoding starch phosphorylase from maize |
| 09/17/1998 | CA2283628A1 Chimeric adenoviral coat protein and methods of using same |
| 09/17/1998 | CA2283626A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | CA2283624A1 Leptospira pathogens |
| 09/17/1998 | CA2283490A1 Fiv vaccine |
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283293A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283108A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 09/17/1998 | CA2282809A1 Cytochrome p450 monooxygenases |
| 09/17/1998 | CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | CA2281980A1 Bacillus thuringiensis toxins |
| 09/17/1998 | CA2281914A1 Pesticidal bacillus thuringiensis strains |
| 09/17/1998 | CA2280997A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 09/17/1998 | CA2254785A1 Antisense base sequences |
| 09/17/1998 | CA2232751A1 Novel compounds |
| 09/16/1998 | EP0864657A1 Oligonucleotides from vts genes of verotoxins producing E.coli and their use |
| 09/16/1998 | EP0864656A2 Method of in vitro transcription for the screening for natural products and other chemical substances |
| 09/16/1998 | EP0864652A1 Expression of a foamy virus envelope protein |
| 09/16/1998 | EP0864651A2 Promoter of the cdc25B gene, its preparation and use |
| 09/16/1998 | EP0864650A2 Stress resistant plant |
| 09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 09/16/1998 | EP0864645A1 (-)-strand rna virus vector having autonomously replicating activity |
| 09/16/1998 | EP0864585A1 Interleukin-18-receptor proteins |
| 09/16/1998 | EP0864088A1 A method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
| 09/16/1998 | EP0864002A1 Methods and compositions for detection of specific nucleotide sequences |
| 09/16/1998 | EP0864001A1 Global amplification of nucleic acids |
| 09/16/1998 | EP0864000A1 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 09/16/1998 | EP0863999A1 Method of detecting telomerase activity |
| 09/16/1998 | EP0863998A1 Double-stranded conformational polymorphism analysis |
| 09/16/1998 | EP0863990A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 09/16/1998 | EP0863989A2 Improved process for the production of semi-synthetic cephalosporins via expandase activity on penicillin g |
| 09/16/1998 | EP0863988A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| 09/16/1998 | EP0863987A2 Vectors and methods for gene transfer to cells |
| 09/16/1998 | EP0863986A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 09/16/1998 | EP0863985A1 Plant gene involved in auxin related signalling pathways |
| 09/16/1998 | EP0863984A1 Methods and compositions for the diagnosis and treatment of cancer |
| 09/16/1998 | EP0863983A2 Starch branching enzyme ii of potato |
| 09/16/1998 | EP0863982A1 Synthetic hpv11 virus-like particles |
| 09/16/1998 | EP0863950A1 An enzyme for dying keratinous fibres |
| 09/16/1998 | EP0863918A1 Method for control of functionality during cross-linking of hemoglobins |
| 09/16/1998 | EP0863913A1 A method to increase the density of antigen on antigen presenting cells |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863910A1 Method for solution phase synthesis of oligonucleotides |
| 09/16/1998 | EP0863766A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/16/1998 | EP0724637B1 Corticotropin-releasing factor 2 receptors |
| 09/16/1998 | EP0706574B1 Methods for peptide synthesis and purification |
| 09/16/1998 | EP0666920B1 Thrombin activatable plasminogen derivatives |
| 09/16/1998 | EP0636185B1 Electrochemical treatment of nucleic acid containing solutions |
| 09/16/1998 | EP0620854B1 Expression and purification of recombinant soluble tissue factor |
| 09/16/1998 | EP0554356B1 A monoclonal antibody |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | CN1193357A Oligonucleotide tags for sorting and identification |
| 09/16/1998 | CN1193356A Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity |
| 09/16/1998 | CN1193355A Alteration of amino acid compositions in seeds |
| 09/16/1998 | CN1193354A 质粒 Plasmid |
| 09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
| 09/16/1998 | CN1193351A Method for identifying attenuated chickenpox virous OKA strain or strain originating therein |